Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C IAS 2013 Sunday 30 July

Why Co-Infections…? Co-infections remain important despite the success of ART roll out Late presenters - CMV Important co-infection even in face of ART - HCV Need for additional political will and funding Testing and treatment often not supported Few guidelines Regional importance Key opportunities CMV: Potential for decentralization of screening, diagnosis and treatment HCV: Potential for paradigm shifting pipeline regimens

Goals: CMV and HCV Examine burden Explore challenges in diagnosis and treatment Share MSF experience Highlight critical and timely opportunities to improve access to diagnosis, treatment and care

Agenda CMV Retinitis – the neglected co-infection Khin Nyein Chan, Nathan Ford Peter Saranchuk Arax Bozadjian **Respondant: Dr. Rewari Hepatitis C – Increasing recognition of importance Nicolas Durier Isabelle Andrieux-Meyer Manica Balasegaram **Respondant: Shiba Phurailatpam